Kern Pharma Biologics, the division of Kern Pharma specialized in biosimilar and hospital medicines, has just launched “Biosimilar Hunters”. This is the first mobile application whose objective is to train doctors and pharmacists in biosimilars, testing their knowledge in this field, in an innovative way through an interactive game.
“Biosimilar Hunters” immerses the player in a fictional story where his goal is to recover all the biosimilar medicines lost after the accident in the Rasvalmor Vault, the largest archive on the planet. Throughout the different levels that the game has, doctors and pharmacists, turned into "Hunters”, will have to overcome a series of tests and challenges related to biosimilar medicines.
In addition to being able to check their knowledge about this type of drugs, the professionals who manage to place themselves in the top three positions in the ranking of "Biosimilar Hunters” will obtain a place for the “Title of expert in Biosimilars”, taught by the University of Alcalá in collaboration with Kern Pharma and accredited with 15 European credits.
The application created by Kern Pharma Biologics It is available in the Apple Store and on Google Play. To participate in this interactive game, doctors and pharmacists just have to enter the application and register by entering their data.
"Biosimilar Hunters” is another initiative promoted by Kern Pharma within the framework of its commitment to innovation and for offering quality training and information about biosimilars to healthcare professionals. Currently, Kern Pharma is a benchmark company in this field, being the only Spanish laboratory that markets three biosimilar monoclonal antibodies in the Iberian Peninsula.